TB Alliance Welcomes WHO Prequalification of Lupin’s Pretomanid Product
NEW YORK (September 12, 2025)—Lupin Limited, a leading pharmaceutical company headquartered in India, has been…
Desmond Tutu TB Centre at Stellenbosch University: Championing Children in the Fight Against TB
In the global fight to end tuberculosis (TB), the Desmond Tutu TB Centre (DTTC) at…
TB Alliance Appoints Dr. Soraya Madani as Senior Vice President, Program and Alliance Management
New York, NY (August 29, 2025) – TB Alliance announced the appointment of Dr. Soraya…
TB Alliance Welcomes WHO Prequalification of Lupin’s Pretomanid Product
NEW YORK (September 12, 2025)—Lupin Limited, a leading pharmaceutical company headquartered in India, has been…
Bangladesh TB Leaders Build Momentum for Shorter, Safer Drug-Resistant Tuberculosis Treatment
Capacity building program in the Philippines empowers Bangladesh NTP managers to scale up BPaL and…
New Study Affirms Financial and Public Health Advantages of Treating Drug-Resistant TB with BPaL-Based Regimens in India
A new economic evaluation has added powerful evidence to the already strong case for wide,…
Funding for TB and Neglected Disease Research Must Increase to Realize Promise of New Technologies
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW…
New Clinical Trial Examines Use of Novel Compound Telacebec in Buruli Ulcer Patients
NEW YORK (August 21, 2024) – In July 2024, a Phase 2 proof-of-concept study was…
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug
Early results presented at the Union World Conference on Lung Health suggest promise of new…
Price of Key DR-TB Medicine Drops 25% as TB Alliance’s Multi-Manufacturer Strategy Expands Access
TB Alliance’s third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving…
TB Alliance Joins Indonesia’s High-Level Meeting on TB
BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by…
TB Alliance Appoints Srishti Gupta and Akshay Vaishnaw as New Members to its Board of Directors
NEW YORK (December 9, 2024)—TB Alliance welcomes Srishti Gupta, MD, MPP, MPhil, and Akshay Vaishnaw,…